Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults: A Randomized Clinical Trial

This randomized clinical trial examines the superiority of a single dose of rituximab vs low-dose mycophenolate mofetil in preventing the recurrence of steroid-dependent nephrotic syndrome in children and young adults.

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Pediatr
Autori principali: Ravani, Pietro, Lugani, Francesca, Drovandi, Stefania, Caridi, Gianluca, Angeletti, Andrea, Ghiggeri, Gian Marco
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2021
Soggetti:
Research Letter
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7900932/
https://ncbi.nlm.nih.gov/pubmed/33616641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.6150
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi